Hostplus
VC Fund
Melbourne, Australia
Hostplus is an industry superannuation fund for the hospitality, tourism, recreation, and sport industries.
- Total investments:
- 63
- Last investment:
- Lead investor:
- 16%
Last updated:
For AI agents: llms.txt
Industries Hostplus invests in
Stages Hostplus invests in
Countries Hostplus invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $6.3M–$49M
- Series B
- $20M–$111M
- Series C
- $13M–$60M
Investment Focus
Industry
- Software 9 (14%)
- Biotechnology 8 (13%)
- Semiconductor 5 (8%)
- Renewable Energy 5 (8%)
- Artificial Intelligence 5 (8%)
Stage
- Series A 16 (25%)
- Series B 14 (22%)
- Series C 12 (19%)
- Series D 6 (10%)
- Series E 5 (8%)
Country
- Australia 21 (33%)
- United Kingdom 11 (17%)
- United States 7 (11%)
- New Zealand 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Belinda Seedsman
Head of Service Operations
|
Head of Service Operations | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Emesent
|
Emesent is a venture-backed technology company that automates the collection and analysis of critical data in challenging underground environments. Our flagship product is the award-winning Hovermap; a LiDAR-mapping and autonomy payload for industrial drones. Hovermap allows drones to fly and map in GPS-denied environments such as undergroundmines.Through Hovermap and other solutions, we deliver revolutionary efficiency, safety and operational insights to underground mines and other GPS-denied environments. Our growing team of experienced roboticists and engineers are dedicated to creating cutting-edge drone autonomy and data analytics for industrial applications. | $10.4M / Convertible Note / Jul 02, 2026 | |
Gradiant
|
Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy. | Series E / May 18, 2026 | |
First Light Fusion
|
First Light Fusion was spun out from the University of Oxford and focuses on researching energy generation by inertial confinement fusion. Its platform explores a number of alternative research directions that harness fundamental physics focusing on power generation and theoretical analysis, detailed numerical simulation, and experimentalvalidation that helps clients to discover a new source of energy. The company directly employs a team of engineers and physicists and collaborates closely with a number of academic organizations, including the University of Oxford, Warwick University, UCL, and Imperial College, London.The company was founded by Professor Yiannis Ventikos and Dr. Nicholas Hawker and is based in Yarnton, Oxfordshire. | $25M / Venture - Series Unknown / Apr 21, 2026 | |
Oxa
|
Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation. The company provides self-driving software that can be configured for various industrial vehicles, paired with modular hardware systems that allow existing fleets to be upgraded. Oxa also offers fleet management software that can integrate withthird-party logistics systems to support coordinated operations. Its solutions focus on improving efficiency, productivity, and safety in environments such as ports, airports, and industrial yards. Oxa incorporates safety and monitoring measures throughout its development and deployment processes, ensuring controlled and explainable vehicle autonomy. The company collaborates with organizations to implement and optimize automation strategies while supporting the adoption and operation of autonomous fleets. | $102.6M / Series D / Mar 04, 2026 | |
Brainomix
|
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time. | $6.5M / Series C / Feb 24, 2026 | |
Diraq
|
Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there. | $13.9M / Series A / Feb 02, 2026 | |
Atisama Therapeutics
|
RAGE Biotech is a biotechnology industry. | $18.9M / Series A / Nov 13, 2025 | |
OXCCU
|
OXCCU develops renewable energy technology with the goal of achieving a circular economy for fuels, chemicals, and plastics. The technology offered by the company combines carbon dioxide from the atmosphere with hydrogen from water and renewable electricity to produce fuels, chemicals, and biodegradable plastics. | $27.9M / Series B / Sep 29, 2025 | |
Airwallex
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $150M / Series F / May 21, 2025 | |
Cardiac Dimensions
|
Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $53M / Series E / Mar 20, 2025 | |
| See all 63 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hostplus invest in?
Hostplus invests primarily in Software, Biotechnology and Semiconductor startups, most often at Series A and Series B stage. Most of the 63 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Hostplus's check size?
Hostplus typically joins rounds of $6.3M–$49M at Series A, $20M–$111M at Series B and $13M–$60M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hostplus participates in.
How do I contact Hostplus?
Public channels for Hostplus include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hostplus?
The team at Hostplus includes Belinda Seedsman (Head of Service Operations). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
